Newstral
Article
Iinvezz.com on 2023-01-24 16:55
J&J’s upbeat guidance brings good news for big pharma
Related news
- EU considers booster doses of J&J’s COVID-19 vaccinepressherald.com
- What’s known about J&J’s vaccine and rare clotsflcourier.com
- IMicrosoft shares rebound on upbeat guidanceinvezz.com
- IAsana stock price forecast after issuing upbeat Q3 sales guidanceinvezz.com
- BEuropean Health Regulators Add Blood Clot Warning to J&J’S Covid-19 Vaccinebarrons.com
- FDA approves 1st cheaper version of J&J’s top drug Remicadereviewtimes.com
- FDA panel backs lower-cost version of J&J’s top-selling drugseattletimes.com
- EU regulator meets to evaluate J&J’s one-shot COVID-19 shotartesianews.com
- HEU Regulator Meets to Evaluate J&J’s One-Shot COVID-19 Shothamodia.com
- J&J’s Single-Dose Covid-19 Vaccine Approved by EU Drug Regulatorwsj.com
- FJ&J cuts guidance as dollar hits salesft.com
- HCDC to Weigh Rare Clot Risk With J&J’s COVID-19 Vaccine as Use Pausedhamodia.com
- FJ&J confirms talks with Actelion over pharma dealft.com
- TFire Destroys J&J’s Roadhouse Restaurantthepeoplestribune.com
- SJ&J’s Top 5: NBA Small Forwardssundial.csun.edu
- SJ&J’s Top 5: NBA Shooting guardssundial.csun.edu
- J&J’s Profits Fall as Dollar Riseswsj.com
- EU regulator recommends using J&J’s one-shot vaccinekansascity.com
- EU regulator approves J&J’s one-shot COVID-19 vaccineThe Fresno Bee